Vascular Solutions (VASC)
Vascular Solutions Accounts Receivable: 12.87M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
VASC Accounts Receivable Rankings
| Overall | 22nd percentile | 2903 of 3770 |
| Sector | 44th percentile | 246 of 443 in Healthcare |
| Industry | 44th percentile | 36 of 65 in Medical Instruments & Supplies |
VASC Accounts Receivable Range, Past 5 Years
| Minimum | 6.771M | Sep 2007 |
| Maximum | 12.87M | Mar 2012 |
| Average | 9.324M |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
You may also be interested in these VASC related companies
VASC News
Mentioned $AUTH here in January. Believe has much more potential. Look at $VASC, especially weekly and monthly charts.
about 3 days ago by StrongestStocks
about 3 days ago by StrongestStocks
Vascular Solutions to Participate in the Jefferies 2012 Global Healthcare Conference
May 21, 4:05PM GlobeNewswire
May 21, 4:05PM GlobeNewswire
Vascular Solutions to Participate in the 2012 InvestMNt Conference Sponsored by the CFA Society of Minnesota
May 10, 4:05PM GlobeNewswire
May 10, 4:05PM GlobeNewswire
Benchmark Starts Vascular Solutions (VASC) at Buy; Catheter Products are Key
May 08, 7:29AM Street Insider
May 08, 7:29AM Street Insider
Vascular Solutions to Participate in Bank of America Merrill Lynch 2012 Health Care Conference
May 01, 4:05PM GlobeNewswire
May 01, 4:05PM GlobeNewswire
Dougherty & Co Upgrades Vascular Solutions (VASC) to Buy; Strong Q1 and Improved Outlook
Apr 25, 11:07AM Street Insider
Apr 25, 11:07AM Street Insider
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Raising PT After Strong Results
Apr 25, 9:44AM Street Insider
Apr 25, 9:44AM Street Insider
Listen to $VASC Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3USg
about 38 days ago by earningscast
about 38 days ago by earningscast
Vascular Solutions, Inc. (VASC) Tops Q1 EPS by 1c; Guides for Q2 and FY
Apr 24, 4:16PM Street Insider
Apr 24, 4:16PM Street Insider
Vascular Solutions, Inc. to Webcast First Quarter Conference Call on Tuesday, April 24th at 3:30pm CST
Apr 10, 4:05PM Business Wire
Apr 10, 4:05PM Business Wire
$VASC filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3A4Q
about 63 days ago by MarketBrief
about 63 days ago by MarketBrief
$VASC forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/2x79
about 73 days ago by RecogniaEvents
about 73 days ago by RecogniaEvents
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Q4 Mixed; 2012 Looks Like Transition Year
Feb 02, 9:33AM Street Insider
Feb 02, 9:33AM Street Insider
$VASC Q4 revs +6%, EPS +8% (ex-tax benefit), maintains 2012 guidance http://stks.co/2CR4 (no pos)
about 121 days ago by wallstreetbean
about 121 days ago by wallstreetbean
Listen to $VASC Q4 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2CLA
about 121 days ago by earningscast
about 121 days ago by earningscast
Vascular Solutions, Inc. (VASC) Reports In-Line Q4 EPS of $0.13, Offers FY12 Guidance
Feb 01, 4:20PM Street Insider
Feb 01, 4:20PM Street Insider
Vascular Solutions Launches Reprocessing Service for ClosureFAST(R) Vein Catheters
Feb 01, 4:05PM GlobeNewswire
Feb 01, 4:05PM GlobeNewswire
Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call on Wednesday, February 1st at 3:30 p.m. CST
Jan 18, 4:05PM Business Wire
Jan 18, 4:05PM Business Wire
BeanScreen for January 1, 2012 | via @WallStreetBean http://stks.co/1jUG $VASC $CVX $QCOR $CHL
about 152 days ago by STNet
about 152 days ago by STNet
Vascular Solutions to Present at the 23rd Annual Piper Jaffray Health Care Conference
Nov 22, 4:15PM GlobeNewswire
Nov 22, 4:15PM GlobeNewswire
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Mixed Q3 and Underwhelming Guidance
Oct 26, 8:45AM Street Insider
Oct 26, 8:45AM Street Insider
Vascular Solutions, Inc. (VASC) Tops Q3 EPS by 2c, Posts Q4 and FY12 Guidance, Raises FY11
Oct 25, 4:40PM Street Insider
Oct 25, 4:40PM Street Insider
weekly chart. still looking to trade this one long if we get a break above 12.6 $VASC http://chart.ly/9rmo24o
about 249 days ago by jasonbgordon
about 249 days ago by jasonbgordon
$VASC broke out of bull flag - love the name - had in depth report on it few weeks ago
about 605 days ago by OptionRadar
about 605 days ago by OptionRadar
$VASC http://chart.ly/7ap75u4 Vascular Solutions a Fantastic 6.5 Year Chart, Posted 2 Months Back as Takeover Play, Still Believe
about 642 days ago by OptionRadar
about 642 days ago by OptionRadar
$VASC big breakout of double top going back 10 years - looks to be attractive takeover candidate
about 716 days ago by OptionRadar
about 716 days ago by OptionRadar
http://chart.ly/ygnfpz $VASC - Thinly traded & small market cap, but co just made acquisition & raised EPS guidance. One to watch
about 736 days ago by ToddinFL
about 736 days ago by ToddinFL
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| VASC | 11.38 | -0.08 | -0.70% | 189.14M |
| VAR | 58.66 | -1.23 | -2.05% | 6.628B |
| VALV | 0.85 | -0.06 | -6.08% | 14.14M |
| VALU | 12.25 | +0.08 | +0.66% | 121.28M |
| VALE | 18.31 | -0.12 | -0.65% | 58.04B |
| VAL | 48.21 | -0.33 | -0.68% | 4.489B |
| V | 115.20 | -2.29 | -1.95% | 93.67B |
| UYM | 29.98 | -0.55 | -1.80% | |
| UXG | 5.74 | -0.01 | -0.17% | |
| UWN | 1.14 | +0.00 | +0.00% | 18.11M |
